Category: Pharmacy - Page 2

How to Avoid Transcription Errors from E-Prescribing Systems

Transcription errors in e-prescribing systems are causing preventable medication mistakes. Learn the 6 proven strategies to stop them-standardized sigs, CancelRx, FHIR integration, and more-backed by real data from U.S. clinics and pharmacies.

How FDA Ensures Generic Drug Quality During Manufacturing

The FDA ensures generic drug quality through strict cGMP standards, unannounced inspections, and rigorous testing. Every generic drug must match the brand-name version in safety, strength, and effectiveness - not by luck, but by design.

Injectable Medication Shortages: Why Hospital Pharmacies Are on the Front Line

Hospital pharmacies are bearing the brunt of a growing crisis: sterile injectable drug shortages. With 226 active shortages in mid-2025, critical medications like anesthetics and chemotherapy drugs are vanishing - forcing staff to make impossible choices and delay life-saving treatments.

Rhabdomyolysis from Medication Interactions: How Common Drugs Can Cause Muscle Breakdown

Rhabdomyolysis from medication interactions is a silent threat - often missed until kidneys fail. Statins, antibiotics, and common combos can trigger muscle breakdown. Know the signs, ask the right questions, and protect yourself.

First-Mover Advantage: How Generic Drug Makers Win Big by Launching First

The first generic drug to hit the market after a patent expires captures up to 80% of sales during its 180-day exclusivity window-and often keeps 30-40% long after. Here’s why being first matters more than price.

Paragraph IV Certifications: How Generic Drug Makers Legally Challenge Brand Patents

Paragraph IV certifications let generic drug makers legally challenge brand-name drug patents before they expire. This Hatch-Waxman Act mechanism triggers lawsuits, grants 180-day exclusivity to winners, and has saved U.S. consumers over $1.7 trillion since 1984.